Search

Amber D. Steele

Examiner (ID: 2430, Phone: (571)272-5538 , Office: P/1676 )

Most Active Art Unit
1658
Art Unit(s)
1654, 1639, 1658, 1676
Total Applications
1302
Issued Applications
628
Pending Applications
166
Abandoned Applications
538

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 16072317 [patent_doc_number] => 20200190145 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-06-18 [patent_title] => ANTIMICROBIAL PEPTIDES AND THEIR USE [patent_app_type] => utility [patent_app_number] => 16/608025 [patent_app_country] => US [patent_app_date] => 2018-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9601 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16608025 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/608025
Antimicrobial peptides and their use Apr 23, 2018 Issued
Array ( [id] => 15895393 [patent_doc_number] => 20200147215 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-05-14 [patent_title] => DRUG CONJUGATES WITH PHOTOCLEAVABLE SOLUBILITY MODULATORS [patent_app_type] => utility [patent_app_number] => 16/607573 [patent_app_country] => US [patent_app_date] => 2018-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17719 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -52 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16607573 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/607573
DRUG CONJUGATES WITH PHOTOCLEAVABLE SOLUBILITY MODULATORS Apr 23, 2018 Abandoned
Array ( [id] => 13490191 [patent_doc_number] => 20180296638 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-10-18 [patent_title] => COMPOSITIONS FOR TREATING HEART DISEASE BY INHIBITING THE ACTION OF mAKAP-ss [patent_app_type] => utility [patent_app_number] => 15/946238 [patent_app_country] => US [patent_app_date] => 2018-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23122 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15946238 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/946238
Compositions for treating heart disease by inhibiting the action of mAKAP-b Apr 4, 2018 Issued
Array ( [id] => 15052341 [patent_doc_number] => 10456446 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-10-29 [patent_title] => Use of human small leucine zipper protein in osteogenesis procedure [patent_app_type] => utility [patent_app_number] => 15/945858 [patent_app_country] => US [patent_app_date] => 2018-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 9344 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15945858 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/945858
Use of human small leucine zipper protein in osteogenesis procedure Apr 4, 2018 Issued
Array ( [id] => 17975542 [patent_doc_number] => 11492390 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-11-08 [patent_title] => Mutant alpha-1-antitrypsin compositions and use thereof [patent_app_type] => utility [patent_app_number] => 16/499534 [patent_app_country] => US [patent_app_date] => 2018-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 21 [patent_no_of_words] => 12423 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16499534 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/499534
Mutant alpha-1-antitrypsin compositions and use thereof Apr 1, 2018 Issued
Array ( [id] => 17974394 [patent_doc_number] => 11491231 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-11-08 [patent_title] => Peptide-oligonucleotide chimeras (POCs) as programmable biomolecular constructs for the assembly of morphologically-tunable soft materials [patent_app_type] => utility [patent_app_number] => 15/941626 [patent_app_country] => US [patent_app_date] => 2018-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 24 [patent_no_of_words] => 7267 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15941626 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/941626
Peptide-oligonucleotide chimeras (POCs) as programmable biomolecular constructs for the assembly of morphologically-tunable soft materials Mar 29, 2018 Issued
Array ( [id] => 13519541 [patent_doc_number] => 20180311313 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-11-01 [patent_title] => COMPOSITION HAVING TISSUE-REPAIRING ACTIVITY, AND USE THEREFOR [patent_app_type] => utility [patent_app_number] => 15/938839 [patent_app_country] => US [patent_app_date] => 2018-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13484 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15938839 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/938839
Composition having tissue-repairing activity, and use therefor Mar 27, 2018 Issued
Array ( [id] => 13328581 [patent_doc_number] => 20180215828 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-08-02 [patent_title] => SYNTHETIC ANTIBODY MIMIC PEPTIDES [patent_app_type] => utility [patent_app_number] => 15/937809 [patent_app_country] => US [patent_app_date] => 2018-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17098 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15937809 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/937809
SYNTHETIC ANTIBODY MIMIC PEPTIDES Mar 26, 2018 Abandoned
Array ( [id] => 18375997 [patent_doc_number] => 20230151079 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-18 [patent_title] => RECOMBINANT PROTEIN AND FRAGMENTS THEREOF, METHOD FOR PRODUCING SAID RECOMBINANT PROTEIN, SYNTHETIC GENE AND USE OF SCULPTIN OR RECOMBINANT PROTEIN FOR PREPARING A MEDICAMENT OR PHARMACEUTICAL COMPOSITION FOR THE PROPHYLAXIS AND/OR TREATMENT OF THROMBOEMBOLIC DISEASES OR AS A DIRECT AND SPECIFIC INHIBITOR OF THROMBIN [patent_app_type] => utility [patent_app_number] => 16/495905 [patent_app_country] => US [patent_app_date] => 2018-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8163 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -2 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16495905 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/495905
Recombinant protein and fragments thereof, method for producing said recombinant protein, synthetic gene and use of sculptin or recombinant protein for preparing a medicament or pharmaceutical composition for the prophylaxis and/or treatment of thromboembolic diseases or as a direct and specific inhibitor of thrombin Mar 20, 2018 Issued
Array ( [id] => 14069499 [patent_doc_number] => 20190083637 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-03-21 [patent_title] => TUMOR CELL-SPECIFIC RESPONSIVE SELF-ASSEMBLING DRUG NANOCONJUGATE [patent_app_type] => utility [patent_app_number] => 15/925830 [patent_app_country] => US [patent_app_date] => 2018-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12676 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15925830 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/925830
Tumor cell-specific responsive self-assembling drug nanoconjugate Mar 19, 2018 Issued
Array ( [id] => 15496229 [patent_doc_number] => 20200048303 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-02-13 [patent_title] => ANTIMICROBIAL PEPTIDES AND METHODS OF MAKING AND USING SAME [patent_app_type] => utility [patent_app_number] => 16/492248 [patent_app_country] => US [patent_app_date] => 2018-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17827 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16492248 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/492248
Antimicrobial peptides and methods of making and using same Mar 11, 2018 Issued
Array ( [id] => 16053233 [patent_doc_number] => 20200188471 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-06-18 [patent_title] => APPLICATION OF SELECTIVE TNFR1 ANTAGONIST PEPTIDE SN10 IN PREPARATION OF DRUGS FOR PREVENTING AND TREATING RHEUMATOID ARTHRITIS [patent_app_type] => utility [patent_app_number] => 16/496866 [patent_app_country] => US [patent_app_date] => 2018-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4434 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16496866 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/496866
APPLICATION OF SELECTIVE TNFR1 ANTAGONIST PEPTIDE SN10 IN PREPARATION OF DRUGS FOR PREVENTING AND TREATING RHEUMATOID ARTHRITIS Mar 1, 2018 Abandoned
Array ( [id] => 15209789 [patent_doc_number] => 20190367581 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-12-05 [patent_title] => VSIG8-BASED CHIMERIC PROTEINS [patent_app_type] => utility [patent_app_number] => 16/484854 [patent_app_country] => US [patent_app_date] => 2018-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24525 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -60 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16484854 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/484854
VSIG8-based chimeric proteins Feb 26, 2018 Issued
Array ( [id] => 15345283 [patent_doc_number] => 20200010533 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-01-09 [patent_title] => Modified serpins for the treatment of bradykinin-mediated disease [patent_app_type] => utility [patent_app_number] => 16/487858 [patent_app_country] => US [patent_app_date] => 2018-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16229 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16487858 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/487858
Modified serpins for the treatment of bradykinin-mediated disease Feb 22, 2018 Issued
Array ( [id] => 16190793 [patent_doc_number] => 20200231642 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-07-23 [patent_title] => PEPTIDE KINASE INHIBITORS AND METHODS OF USE THEREOF [patent_app_type] => utility [patent_app_number] => 16/486832 [patent_app_country] => US [patent_app_date] => 2018-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11588 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16486832 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/486832
PEPTIDE KINASE INHIBITORS AND METHODS OF USE THEREOF Feb 18, 2018 Abandoned
Array ( [id] => 19273312 [patent_doc_number] => 12023419 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-07-02 [patent_title] => Prokaryotic collagen therapeutics for postoperative adhesions [patent_app_type] => utility [patent_app_number] => 15/898482 [patent_app_country] => US [patent_app_date] => 2018-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 23 [patent_no_of_words] => 12393 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15898482 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/898482
Prokaryotic collagen therapeutics for postoperative adhesions Feb 16, 2018 Issued
Array ( [id] => 17007098 [patent_doc_number] => 20210238259 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-05 [patent_title] => FACTOR IX FUSION PROTEINS AND METHODS OF MAKING AND USING SAME [patent_app_type] => utility [patent_app_number] => 16/478747 [patent_app_country] => US [patent_app_date] => 2018-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38133 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16478747 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/478747
FACTOR IX FUSION PROTEINS AND METHODS OF MAKING AND USING SAME Jan 30, 2018 Abandoned
Array ( [id] => 12769981 [patent_doc_number] => 20180148495 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-05-31 [patent_title] => VARIANT FACTOR VIII POLYPEPTIDES AND METHODS OF THEIR PRODUCTION AND USE [patent_app_type] => utility [patent_app_number] => 15/878012 [patent_app_country] => US [patent_app_date] => 2018-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14608 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15878012 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/878012
Variant factor VIII polypeptides and methods of their production and use Jan 22, 2018 Issued
Array ( [id] => 12746527 [patent_doc_number] => 20180140676 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-05-24 [patent_title] => RAPID-ACTING INSULIN COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 15/868272 [patent_app_country] => US [patent_app_date] => 2018-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14971 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15868272 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/868272
Rapid-acting insulin compositions Jan 10, 2018 Issued
Array ( [id] => 15178119 [patent_doc_number] => 20190359651 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-11-28 [patent_title] => CENTRAL NERVOUS SYSTEM HOMING PEPTIDES AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 16/477125 [patent_app_country] => US [patent_app_date] => 2018-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9849 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16477125 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/477125
Central nervous system homing peptides and uses thereof Jan 9, 2018 Issued
Menu